Companion Diagnostics Market by Product & Service (Assay, Kit, Software & Service), Technology (PCR, NGS, ISH, IHC), Indication (Breast, Lung & Colorectal Cancer, Cardiovascular Disease), End-User (Pharma Companies, CRO), Region - Global Forecast to 2024

Companion Diagnostics Market by Product & Service (Assay, Kit, Software & Service), Technology (PCR, NGS, ISH, IHC), Indication (Breast, Lung & Colorectal Cancer, Cardiovascular Disease), End-User (Pharma Companies, CRO), Region - Global Forecast to 2024

“The companion diagnostics market is estimated to grow at a CAGR of 15.7%”
The companion diagnostics market is projected to reach 7.3 billion by 2024 from USD 3.5 billion in 2019, at a CAGR of 15.7%. The growth of the companion diagnostics industry is tied primarily to its various advantages, the growing need for targeted therapy, the increasing importance of personalized medicine. Moreover, the increasing global incidence of cancer, ever-increasing application areas of companion diagnostics, rising demand for next-generation sequencing, the growing significance of companion diagnostics in drug development, and the increasing number of clinical trials are expected to present growth opportunities for players in the market. However, the high cost of companion diagnostic tests and the uncertain reimbursement scenario in different regions affect market growth to a certain extent during the forecast period.

“Cancer segment to witness the highest growth during the forecast period”
The cancer segment is estimated to grow at the highest CAGR during the forecast period. This can be attributed primarily to the increasing global incidence of cancer, the growing role of companion diagnostics in personalized medicine treatment for cancer, the rising utility of biomarkers in the diagnosis of cancer, technological advancements in cancer diagnostics at the molecular level, and the availability of funding for cancer research.

“Pharmaceutical & biopharmaceutical companies segment to grow at the highest CAGR in the companion diagnostics market, by end-user”
The major factors driving the demand for pharmaceutical & biopharmaceutical companies in companion diagnostics are growing prominence in drug development and the growing importance of companion diagnostic biomarkers. The increasing demand for personalized medicine as well as the high demand for targeted therapies for various diseases and disorders are also expected to drive the demand and uptake of companion diagnostics among pharmaceutical & biopharmaceutical companies.

“APAC market to witness the highest growth during the forecast period”
Asia Pacific is estimated to be the fastest-growing regional market for companion diagnostics during the forecast period. The high incidence of cancer, growing proteomics & genomics research, increasing research funding, rising investments by pharmaceutical and biotechnology companies, and growing awareness about personalized therapeutics in several APAC countries are some of the major factors driving the growth of this market.

A breakdown of the primary participants in this report is provided below:
By Company Type: Tier 1-35%, Tier 2-45%, and Tier 3-20%
By Designation: C-level-35%, Director Level-25%, and Others-40%
By Region: North America-45%, Europe-20%, Asia Pacific-30%, Rest of the World (RoW)-5%

The prominent players operating in the global companion diagnostics market are F. Hoffmann-La Roche AG (Switzerland), Agilent Technologies, Inc. (US), QIAGEN N.V. (Germany), Abbott Laboratories, Inc. (US), Almac Group (UK), Danaher Corporation (US), Illumina, Inc. (US), bioMérieux SA (France), Myriad Genetics, Inc., (US), Sysmex Corporation (Japan), Thermo Fisher Scientific Inc. (US), Abnova Corporation (Taiwan), and Guardant Health, Inc. (US).

Research Coverage:
This report analyzes the market for various companion diagnostics and their adoption patterns. It aims at estimating the size and future growth potential of the global companion diagnostics market as well as its segments (by product & service, technology, indication, end-user, and region). The report also includes an in-depth competitive analysis of key market players along with their company profiles, product offerings, and recent developments.

Reasons to Buy the Report
This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one, or any combination of the below mentioned five strategies for strengthening their market presence.

Market Penetration: Comprehensive information on the product portfolios offered by the top players in the global companion diagnostics market
Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and service launches in the global companion diagnostics market
Market Development: Comprehensive information on the lucrative emerging regions
Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the global companion diagnostics market
Competitive Assessment: In-depth assessment of product offered, market shares, growth strategies, and revenue analysis of leading players in the global companion diagnostics market


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
    • MARKET SCOPE
      • MARKETS COVERED
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY
      • Table STANDARD CURRENCY CONVERSION RATES
    • LIMITATIONS
    • STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • RESEARCH DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • MARKET SIZE ESTIMATION
    • MARKET BREAKDOWN AND DATA TRIANGULATION
    • ASSUMPTIONS FOR THE STUDY
  • EXECUTIVE SUMMARY
    • Table COMPANION DIAGNOSTICS MARKET SNAPSHOT, 2019 VS. 2024
  • PREMIUM INSIGHTS
    • COMPANION DIAGNOSTICS: MARKET OVERVIEW
    • ASIA PACIFIC: COMPANION DIAGNOSTICS MARKET, BY END USER (2018)
    • REGIONAL MIX: COMPANION DIAGNOSTICS MARKET
    • COMPANION DIAGNOSTICS MARKET: DEVELOPING VS. DEVELOPED COUNTRIES
    • GEOGRAPHICAL SNAPSHOT OF THE COMPANION DIAGNOSTICS MARKET
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DYNAMICS
      • DRIVERS
      • RESTRAINTS
        • Table COMPANION DIAGNOSTICS REIMBURSEMENT SCENARIO WORLDWIDE
      • OPPORTUNITIES
        • Table PARTNERSHIPS & COLLABORATIONS FOR DEVELOPING NGS-BASED COMPANION DIAGNOSTIC TESTS
        • Table LIST OF CLINICAL TRIALS FOR COMPANION DIAGNOSTICS
      • CHALLENGES
  • INDUSTRY INSIGHTS
    • INTRODUCTION
    • INDUSTRY TRENDS
      • GROWING FOCUS ON LIQUID BIOPSY IN COMPANION DIAGNOSTICS
      • INCREASING COLLABORATIONS
        • Table RECENT COLLABORATIONS IN THE COMPANION DIAGNOSTICS MARKET
    • REGULATORY ANALYSIS
      • NORTH AMERICA
        • Table US: CLASSIFICATION OF MEDICAL DEVICES
      • EUROPE
      • ASIA PACIFIC
        • Table JAPAN: CLASSIFICATION OF MEDICAL DEVICES
        • Table CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
        • Table INDIA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
      • BRAZIL
    • PRODUCT PIPELINE ANALYSIS
      • Table COMPANION DIAGNOSTICS PRODUCT PIPELINE ANALYSIS, BY MARKET PLAYER: CURRENT MARKET SCENARIO
  • COMPANION DIAGNOSTICS MARKET, BY PRODUCT & SERVICE
    • INTRODUCTION
      • Table COMPANION DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
    • ASSAYS, KITS, & REAGENTS
      • THE VOLUME OF CDX TESTS PERFORMED IN LABORATORIES IS INCREASING, WHICH SUPPORTS THE ADOPTION OF ASSAYS & KITS
        • Table COMPANION DIAGNOSTICS MARKET FOR ASSAYS, KITS, & REAGENTS, BY COUNTRY, 2017-2024 (USD MILLION)
    • SOFTWARE & SERVICES
      • THE NEED FOR EFFECTIVE DATA MANAGEMENT SOFTWARE WITHIN LABORATORIES IS INCREASING, CONTRIBUTING TO THE GROWTH OF THE COMPANION DIAGNOSTIC SOFTWARE & SERVICES MARKET
        • Table COMPANION DIAGNOSTICS MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2017-2024 (USD MILLION)
  • COMPANION DIAGNOSTICS MARKET, BY TECHNOLOGY
    • INTRODUCTION
      • Table COMPANION DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
    • POLYMERASE CHAIN REACTION (PCR)
      • GROWING APPLICATIONS OF PCR TECHNOLOGIES IN THE FIELD OF PERSONALIZED MEDICINE AND COMPANION DIAGNOSTICS DRIVE THE GROWTH OF THIS SEGMENT
        • Table COMPARISON OF TISSUE SEQUENCING PLATFORMS FOR THE DETECTION OF RAS/BRAF MUTATION
        • Table MAJOR PCR TESTS/KITS AVAILABLE IN THE MARKET
        • Table COMPANION DIAGNOSTICS MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2017-2024 (USD MILLION)
    • NEXT-GENERATION SEQUENCING (NGS)
      • THE NGS SEGMENT IS EXPECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
        • Table MAJOR NGS TESTS/KITS AVAILABLE IN THE MARKET
        • Table COMPANION DIAGNOSTICS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2017-2024 (USD MILLION)
    • IN SITU HYBRIDIZATION (ISH)
      • INCREASING ADOPTION OF ISH IS MAINLY DUE TO ADVANCEMENTS IN HYBRIDIZATION AND ITS DEMAND IN SMALL-TUMOR DIAGNOSTICS
        • Table MAJOR ISH TESTS/KITS AVAILABLE IN THE MARKET
        • Table COMPANION DIAGNOSTICS MARKET FOR IN SITU HYBRIDIZATION, BY COUNTRY, 2017-2024 (USD MILLION)
    • IMMUNOHISTOCHEMISTRY (IHC)
      • INCREASING DEMAND FOR USER-FRIENDLY AND COST-EFFECTIVE TECHNOLOGIES IN COMPANION DIAGNOSTICS TO DRIVE THE GROWTH OF THIS SEGMENT
        • Table MAJOR IHC TESTS/KITS AVAILABLE IN THE MARKET
        • Table COMPANION DIAGNOSTICS MARKET FOR IMMUNOHISTOCHEMISTRY, BY COUNTRY, 2017-2024 (USD MILLION)
    • OTHER TECHNOLOGIES
      • Table COMPANION DIAGNOSTICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2017-2024 (USD MILLION)
  • COMPANION DIAGNOSTICS MARKET, BY INDICATION
    • INTRODUCTION
      • Table COMPANION DIAGNOSTICS MARKET, BY INDICATION, 2017-2024 (USD MILLION)
    • CANCER
      • Table COMPANION DIAGNOSTICS MARKET FOR CANCER, BY TYPE, 2017-2024 (USD MILLION)
      • Table COMPANION DIAGNOSTICS MARKET FOR CANCER, BY COUNTRY, 2017-2024 (USD MILLION)
      • BREAST CANCER
        • Table COMPANION DIAGNOSTICS MARKET FOR BREAST CANCER, BY COUNTRY, 2017-2024 (USD MILLION)
      • LUNG CANCER
        • Table COMPANION DIAGNOSTICS MARKET FOR LUNG CANCER, BY COUNTRY, 2017-2024 (USD MILLION)
      • COLORECTAL CANCER
        • Table COMPANION DIAGNOSTICS MARKET FOR COLORECTAL CANCER, BY COUNTRY, 2017-2024 (USD MILLION)
      • MELANOMA
        • Table COMPANION DIAGNOSTICS MARKET FOR MELANOMA, BY COUNTRY, 2017-2024 (USD MILLION)
      • GASTRIC CANCER
        • Table COMPANION DIAGNOSTICS MARKET FOR GASTRIC CANCER, BY COUNTRY, 2017-2024 (USD MILLION)
    • NEUROLOGICAL DISEASES
      • GROWING NUMBER OF DIAGNOSTIC TECHNOLOGIES FOR THE TREATMENT OF NEUROLOGICAL DISEASES TO BOOST THE ADOPTION OF COMPANION DIAGNOSTICS IN THIS SEGMENT
        • Table COMPANION DIAGNOSTICS MARKET FOR NEUROLOGICAL DISEASES, BY COUNTRY, 2017-2024 (USD MILLION)
    • INFECTIOUS DISEASES
      • GROWING FOCUS OF COMPANION DIAGNOSTIC PLAYERS ON ORPHAN INDICATIONS TO PROPEL THE GROWTH OF THIS SEGMENT DURING THE FORECAST PERIOD
        • Table COMPANION DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2017-2024 (USD MILLION)
    • CARDIOVASCULAR DISEASES
      • GROWING DEMAND FOR TARGETED THERAPIES DUE TO HIGH INCIDENCE AND MORTALITY RATE OF CARDIOVASCULAR DISEASES TO DRIVE GROWTH IN THIS SEGMENT
        • Table COMPANION DIAGNOSTICS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2017-2024 (USD MILLION)
    • OTHER INDICATIONS
      • Table COMPANION DIAGNOSTICS MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2017-2024 (USD MILLION)
  • COMPANION DIAGNOSTICS MARKET, BY END USER
    • INTRODUCTION
      • Table COMPANION DIAGNOSTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
    • PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
      • WIDE USAGE OF COMPANION DIAGNOSTICS IN PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES OWING TO THEIR GROWING PROMINENCE IN DRUG DEVELOPMENT TO DRIVE MARKET GROWTH
        • Table COMPANION DIAGNOSTICS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2017-2024 (USD MILLION)
    • REFERENCE LABORATORIES
      • GROWING INCIDENCE OF DISEASES SUCH AS CANCER AND THE RISING DEMAND FOR TARGETED THERAPIES TO DRIVE THE GROWTH OF THIS END-USER SEGMENT
        • Table COMPANION DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2017-2024 (USD MILLION)
    • CONTRACT RESEARCH ORGANIZATIONS
      • CROS OFFER A COMPLETE RANGE OF COMPANION DIAGNOSTIC SERVICES RANGING FROM COMPANION DIAGNOSTIC DEVELOPMENT TO TARGETED THERAPY-RELATED CLINICAL TRIALS
        • Table COMPANION DIAGNOSTICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2017-2024 (USD MILLION)
    • OTHER END USERS
      • Table COMPANION DIAGNOSTICS MARKET FOR OTHER END USERS, BY COUNTRY, 2017-2024 (USD MILLION)
  • COMPANION DIAGNOSTICS MARKET, BY REGION
    • INTRODUCTION
      • Table COMPANION DIAGNOSTICS MARKET, BY REGION, 2017-2024 (USD MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: COMPANION DIAGNOSTICS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
      • Table NORTH AMERICA: COMPANION DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
      • Table NORTH AMERICA: COMPANION DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
      • Table NORTH AMERICA: COMPANION DIAGNOSTICS MARKET, BY INDICATION, 2017-2024 (USD MILLION)
      • Table NORTH AMERICA: COMPANION DIAGNOSTICS MARKET FOR CANCER, BY TYPE, 2017-2024 (USD MILLION)
      • Table NORTH AMERICA: COMPANION DIAGNOSTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
      • US
        • Table US: KEY MACROINDICATORS
        • Table US: COMPANION DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
        • Table US: COMPANION DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
        • Table US: COMPANION DIAGNOSTICS MARKET, BY INDICATION, 2017-2024 (USD MILLION)
        • Table US: COMPANION DIAGNOSTICS MARKET FOR CANCER, BY TYPE, 2017-2024 (USD MILLION)
        • Table US: COMPANION DIAGNOSTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
      • CANADA
        • Table CANADA: KEY MACROINDICATORS
        • Table CANADA: COMPANION DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
        • Table CANADA: COMPANION DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
        • Table CANADA: COMPANION DIAGNOSTICS MARKET, BY INDICATION, 2017-2024 (USD MILLION)
        • Table CANADA: COMPANION DIAGNOSTICS MARKET FOR CANCER, BY TYPE, 2017-2024 (USD MILLION)
        • Table CANADA: COMPANION DIAGNOSTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
    • EUROPE
      • Table EUROPE: COMPANION DIAGNOSTICS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
      • Table EUROPE: COMPANION DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
      • Table EUROPE: COMPANION DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
      • Table EUROPE: COMPANION DIAGNOSTICS MARKET, BY INDICATION, 2017-2024 (USD MILLION)
      • Table EUROPE: COMPANION DIAGNOSTICS MARKET FOR CANCER, BY TYPE, 2017-2024 (USD MILLION)
      • Table EUROPE: COMPANION DIAGNOSTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
      • GERMANY
        • Table GERMANY: KEY MACROINDICATORS
        • Table GERMANY: COMPANION DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
        • Table GERMANY: COMPANION DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
        • Table GERMANY: COMPANION DIAGNOSTICS MARKET, BY INDICATION, 2017-2024 (USD MILLION)
        • Table GERMANY: COMPANION DIAGNOSTICS MARKET FOR CANCER, BY TYPE, 2017-2024 (USD MILLION)
        • Table GERMANY: COMPANION DIAGNOSTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
      • UK
        • Table UK: KEY MACROINDICATORS
        • Table UK: COMPANION DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
        • Table UK: COMPANION DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
        • Table UK: COMPANION DIAGNOSTICS MARKET, BY INDICATION, 2017-2024 (USD MILLION)
        • Table UK: COMPANION DIAGNOSTICS MARKET FOR CANCER, BY TYPE, 2017-2024 (USD MILLION)
        • Table UK: COMPANION DIAGNOSTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
      • SWITZERLAND
        • Table SWITZERLAND: KEY MACROINDICATORS
        • Table SWITZERLAND: COMPANION DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
        • Table SWITZERLAND: COMPANION DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
        • Table SWITZERLAND: COMPANION DIAGNOSTICS MARKET, BY INDICATION, 2017-2024 (USD MILLION)
        • Table SWITZERLAND: COMPANION DIAGNOSTICS MARKET FOR CANCER, BY TYPE, 2017-2024 (USD MILLION)
        • Table SWITZERLAND: COMPANION DIAGNOSTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
      • FRANCE
        • Table FRANCE: KEY MACROINDICATORS
        • Table FRANCE: COMPANION DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
        • Table FRANCE: COMPANION DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
        • Table FRANCE: COMPANION DIAGNOSTICS MARKET, BY INDICATION, 2017-2024 (USD MILLION)
        • Table FRANCE: COMPANION DIAGNOSTICS MARKET FOR CANCER, BY TYPE, 2017-2024 (USD MILLION)
        • Table FRANCE: COMPANION DIAGNOSTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
      • ITALY
        • Table ITALY: KEY MACROINDICATORS
        • Table ITALY: COMPANION DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
        • Table ITALY: COMPANION DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
        • Table ITALY: COMPANION DIAGNOSTICS MARKET, BY INDICATION, 2017-2024 (USD MILLION)
        • Table ITALY: COMPANION DIAGNOSTICS MARKET FOR CANCER, BY TYPE, 2017-2024 (USD MILLION)
        • Table ITALY: COMPANION DIAGNOSTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
      • SPAIN
        • Table SPAIN: KEY MACROINDICATORS
        • Table SPAIN: COMPANION DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
        • Table SPAIN: COMPANION DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
        • Table SPAIN: COMPANION DIAGNOSTICS MARKET, BY INDICATION, 2017-2024 (USD MILLION)
        • Table SPAIN: COMPANION DIAGNOSTICS MARKET FOR CANCER, BY TYPE, 2017-2024 (USD MILLION)
        • Table SPAIN: COMPANION DIAGNOSTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
      • REST OF EUROPE
        • Table ROE: COMPANION DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
        • Table ROE: COMPANION DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
        • Table ROE: COMPANION DIAGNOSTICS MARKET, BY INDICATION, 2017-2024 (USD MILLION)
        • Table ROE: COMPANION DIAGNOSTICS MARKET FOR CANCER, BY TYPE, 2017-2024 (USD MILLION)
        • Table ROE: COMPANION DIAGNOSTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
    • ASIA PACIFIC
      • Table APAC: COMPANION DIAGNOSTICS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
      • Table APAC: COMPANION DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
      • Table APAC: COMPANION DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
      • Table APAC: COMPANION DIAGNOSTICS MARKET, BY INDICATION, 2017-2024 (USD MILLION)
      • Table APAC: COMPANION DIAGNOSTICS MARKET FOR CANCER, BY TYPE, 2017-2024 (USD MILLION)
      • Table APAC: COMPANION DIAGNOSTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
      • JAPAN
        • Table JAPAN: KEY MACROINDICATORS
        • Table JAPAN: COMPANION DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
        • Table JAPAN: COMPANION DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
        • Table JAPAN: COMPANION DIAGNOSTICS MARKET, BY INDICATION, 2017-2024 (USD MILLION)
        • Table JAPAN: COMPANION DIAGNOSTICS MARKET FOR CANCER, BY TYPE, 2017-2024 (USD MILLION)
        • Table JAPAN: COMPANION DIAGNOSTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
      • CHINA
        • Table CHINA: KEY MACROINDICATORS
        • Table CHINA: COMPANION DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
        • Table CHINA: COMPANION DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
        • Table CHINA: COMPANION DIAGNOSTICS MARKET, BY INDICATION, 2017-2024 (USD MILLION)
        • Table CHINA: COMPANION DIAGNOSTICS MARKET FOR CANCER, BY TYPE, 2017-2024 (USD MILLION)
        • Table CHINA: COMPANION DIAGNOSTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
      • INDIA
        • Table INDIA: KEY MACROINDICATORS
        • Table INDIA: COMPANION DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
        • Table INDIA: COMPANION DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
        • Table INDIA: COMPANION DIAGNOSTICS MARKET, BY INDICATION, 2017-2024 (USD MILLION)
        • Table INDIA: COMPANION DIAGNOSTICS MARKET FOR CANCER, BY TYPE, 2017-2024 (USD MILLION)
        • Table INDIA: COMPANION DIAGNOSTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
      • AUSTRALIA
        • Table AUSTRALIA: KEY MACROINDICATORS
        • Table AUSTRALIA: COMPANION DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
        • Table AUSTRALIA: COMPANION DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
        • Table AUSTRALIA: COMPANION DIAGNOSTICS MARKET, BY INDICATION, 2017-2024 (USD MILLION)
        • Table AUSTRALIA: COMPANION DIAGNOSTICS MARKET FOR CANCER, BY TYPE, 2017-2024 (USD MILLION)
        • Table AUSTRALIA: COMPANION DIAGNOSTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
      • REST OF ASIA PACIFIC
        • Table ROAPAC: COMPANION DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
        • Table ROAPAC: COMPANION DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
        • Table ROAPAC: COMPANION DIAGNOSTICS MARKET, BY INDICATION, 2017-2024 (USD MILLION)
        • Table ROAPAC: COMPANION DIAGNOSTICS MARKET FOR CANCER, BY TYPE, 2017-2024 (USD MILLION)
        • Table ROAPAC: COMPANION DIAGNOSTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
    • LATIN AMERICA
      • Table LATIN AMERICA: COMPANION DIAGNOSTICS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
      • Table LATIN AMERICA: COMPANION DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
      • Table LATIN AMERICA: COMPANION DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
      • Table LATIN AMERICA: COMPANION DIAGNOSTICS MARKET, BY INDICATION, 2017-2024 (USD MILLION)
      • Table LATIN AMERICA: COMPANION DIAGNOSTICS MARKET FOR CANCER, BY TYPE, 2017-2024 (USD MILLION)
      • Table LATIN AMERICA: COMPANION DIAGNOSTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
      • BRAZIL
        • Table BRAZIL: KEY MACROINDICATORS
        • Table BRAZIL: COMPANION DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
        • Table BRAZIL: COMPANION DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
        • Table BRAZIL: COMPANION DIAGNOSTICS MARKET, BY INDICATION, 2017-2024 (USD MILLION)
        • Table BRAZIL: COMPANION DIAGNOSTICS MARKET FOR CANCER, BY TYPE, 2017-2024 (USD MILLION)
        • Table BRAZIL: COMPANION DIAGNOSTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
      • MEXICO
        • Table MEXICO: KEY MACROINDICATORS
        • Table MEXICO: COMPANION DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
        • Table MEXICO: COMPANION DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
        • Table MEXICO: COMPANION DIAGNOSTICS MARKET, BY INDICATION, 2017-2024 (USD MILLION)
        • Table MEXICO: COMPANION DIAGNOSTICS MARKET FOR CANCER, BY TYPE, 2017-2024 (USD MILLION)
        • Table MEXICO: COMPANION DIAGNOSTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
      • REST OF LATIN AMERICA
        • Table ROLA: COMPANION DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
        • Table ROLA: COMPANION DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
        • Table ROLA: COMPANION DIAGNOSTICS MARKET, BY INDICATION, 2017-2024 (USD MILLION)
        • Table ROLA: COMPANION DIAGNOSTICS MARKET FOR CANCER, BY TYPE, 2017-2024 (USD MILLION)
        • Table ROLA: COMPANION DIAGNOSTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
    • MIDDLE EAST & AFRICA
      • RISING CANCER INCIDENCE RATE HAS ATTRACTED STAKEHOLDER ATTENTION TO REGIONAL MARKETS IN MEA
        • Table MEA: COMPANION DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
        • Table MEA: COMPANION DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
        • Table MEA: COMPANION DIAGNOSTICS MARKET, BY INDICATION, 2017-2024 (USD MILLION)
        • Table MEA: COMPANION DIAGNOSTICS MARKET FOR CANCER, BY TYPE, 2017-2024 (USD MILLION)
        • Table MEA: COMPANION DIAGNOSTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
      • Table GROWTH STRATEGY MATRIX (2016-2019)
    • MARKET SHARE ANALYSIS
    • COMPETITIVE LEADERSHIP MAPPING, 2018
    • VENDOR INCLUSION CRITERIA
    • VENDOR DIVE
      • VISIONARY LEADERS
      • INNOVATORS
      • EMERGING COMPANIES
      • DYNAMIC DIFFERENTIATORS
    • COMPETITIVE SITUATIONS AND TRENDS
      • Table PRODUCT LAUNCHES & APPROVALS, 2016-2019
      • PARTNERSHIPS, COLLABORATIONS, & AGREEMENTS
        • Table PARTNERSHIPS, COLLABORATIONS, & AGREEMENTS, 2016-2019
      • ACQUISITIONS
        • Table ACQUISITIONS, 2016-2019
      • EXPANSIONS
        • Table EXPANSIONS, 2016-2019
  • COMPANY PROFILES
    • F. HOFFMANN-LA ROCHE AG
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • AGILENT TECHNOLOGIES, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • QIAGEN N.V.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • ABBOTT LABORATORIES, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • ALMAC GROUP
      • BUSINESS OVERVIEW
      • SERVICES OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • DANAHER CORPORATION
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • ILLUMINA INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • BIOMÉRIEUX SA
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • MNM VIEW
    • MYRIAD GENETICS, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • SYSMEX CORPORATION
      • BUSINESS OVERVIEW
      • PRODUCTS & SERVICES OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • THERMO FISHER SCIENTIFIC, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS & SERVICES OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • ABNOVA CORPORATION
      • BUSINESS OVERVIEW
      • SERVICES OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • GUARDANT HEALTH, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
  • APPENDIX
    • INSIGHTS FROM INDUSTRY EXPERTS
    • DISCUSSION GUIDE
    • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook